Interpreting and Applying cGVHD Clinical Trial Data
Charles Turck, PharmD, BCPS, BCCCP
Christopher Graham, MD
Evolving epNEC Care: From Default Regimens to Precision-Driven Strategies
Alexandria May, PharmD, BCPS
Chandrikha Chandrasekharan, MBBS
Advancing Management of Extrapulmonary NEC: The Emerging Role of DLL3
Rohit Thummalapalli, MD
Decoding epNECs: Diagnostic Challenges and Emerging Strategies
Brian P. McDonough, MD, FAAFP
Andrew E. Hendifar, MD
Key Differences in Pulmonary and Extrapulmonary NEC Management
Lowell B. Anthony, MD, FACP
Survival Outcomes in Squamous Cell Carcinoma of the Anal Canal: POD1UM-303 Data
Stacey Cohen, MD
Optimizing cGVHD Treatment Decisions in the Second- and Third-Line Settings
Stephanie Gregory, CNP
Real-World Strategies for Complex cGVHD Treatment Decisions
Doris M. Ponce, MD, MS
Making Mechanism-Based Treatment Decisions in cGVHD
Alicia Lieberman, MD, MS
Real-World Cases in Squamous Cell Carcinoma of the Anal Canal Care
Madison Conces, MD
Midhun Malla, MD
Updates in AML Care: Evolving ASH Guidelines for Older Adults
Shelina Ramnarine, PhD
Mikkael A. Sekeres, MD, MS
Venetoclax and Palbociclib in AML: Exploring New Findings
Ryan Quigley
Jeffrey Tyner, PhD
Melissa Stewart, PhD
Expanding Access to CAR T-Cell Therapy in R/R Myeloma Care
Tara Graff, DO, MS
Surbhi Sidana, MD
Optimizing Care for Older Adults With FLT3-Mutated AML
Nicholas Short, MD
How the 2025 IMWG Guidelines are Reshaping Sequencing in R/R Multiple Myeloma
Jennifer Caudle, DO, FACOFP
Mansi R. Shah, MD
Surgical Insights on Gastroesophageal Cancer: Balancing Surveillance and Intervention
Daniela Molena, MD
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We're glad to see you're enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.